Synonyms: SPR-719 | VXc-486
Compound class:
Synthetic organic
Comment: SPR719 is a novel aminobenzimidazole antibacterial compound that is a dual Inhibitor of bacterial DNA gyrase and DNA topoisomerase 4 [1]. An orally administered prodrug, fobrepodacin (SPR720), is being developed for the treatment of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
|
|
Bioactivity Comments |
SPR719 inhibits Staphylococcus aureus DNA gyrase with a Ki of 9 nM and DNA topoisomerase 4 with a Ki of 12 nM [1]. It is a potent inhibitor in vitro of both drug-sensitive and drug-resistant Mycobacterium tuberculosis laboratory strains and clinical isolates (MIC against M. tuberculosis H37Rv is in the range of of 0.12-0.25 μg/ml) [2]. It also inhibits the growth of Mycobacterium abscessus, Mycobacterium avium Complex (MAC), and Mycobacterium kansasii. |